Evaluation of an Accelerated Hepatitis B Vaccination Schedule in Post‐Hematopoietic Stem Cell Transplant Pediatric Patients
Pediatric Blood & Cancer · 2026
DOI: 10.1002/pbc.70006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Rina Yue Ling Ong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacy, KK Women's and Children's Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Hepatitis B Vaccines, Hepatitis B, Immunization Schedule. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Revaccination in pediatric post‐hematopoietic stem cell transplant (HSCT) patients is important for preventing vaccine‐preventable infections. Published guidelines recommend revaccination based on time elapsed post‐transplant, though the optimal timing remains unclear. Since May 2019, our institution adopted an accelerated revaccination schedule commencing 6 months post‐HSCT and we report our experience. Our study supports the accelerated revaccination schedule, as most pediatric patients were able to mount sufficient immune responses using hepatitis B seroconversion as a surrogate. With the accelerated revaccination schedule, this could also potentially shorten the vulnerable period where patients are at risk of severe vaccine‐preventable infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacy, KK Women's and Children's Hospital, Singapore, Singapore.
- Duke-NUS Medical School, Singapore, Singapore.
- Department of Pediatric Subspecialties, Rheumatology and Immunology Service, KK Women's and Children's Hospital, Singapore, Singapore.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore.
ORCID-Profile: Rina Yue Ling Ong, Su-Wan Bianca Chan, Swee Sen Kwek, Shui Yen Soh, Chester Junjie Huang
Zitieren
APA
Ong, R. Y. L., Loe, M. W. C., Chan, S. B., Loh, K. M., Kwek, S. S., Chong, C. Y., Li, J., Thoon, K. C., Nadua, K. D., Kam, K. Q., Yung, C. F., Soh, S. Y., Tan, A. M., Liew, W. K., Huang, C. J., Seow, C. W., Shetty, S., & Tan, N. W. H. (2026). Evaluation of an Accelerated Hepatitis B Vaccination Schedule in Post‐Hematopoietic Stem Cell Transplant Pediatric Patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.70006
Vancouver
Ong RYL, Loe MWC, Chan SB, Loh KM, Kwek SS, Chong CY, et al. Evaluation of an Accelerated Hepatitis B Vaccination Schedule in Post‐Hematopoietic Stem Cell Transplant Pediatric Patients. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.70006
BibTeX
@article{Ong2026,
author = {Ong, Rina Yue Ling and Loe, Marcus Wing Choy and Chan, Su-Wan Bianca and Loh, Kent Mun and Kwek, Swee Sen and Chong, Chia Yin and Li, Jiahui and Thoon, Koh Cheng and Nadua, Karen Donceras and Kam, Kai-Qian and Yung, Chee Fu and Soh, Shui Yen and Tan, Ah Moy and Liew, Woei Kang and Huang, Chester Junjie and Seow, Christopher Wen-Xing and Shetty, Shanti and Tan, Natalie Woon Hui},
title = {Evaluation of an Accelerated Hepatitis B Vaccination Schedule in Post‐Hematopoietic Stem Cell Transplant Pediatric Patients},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/pbc.70006}
}
EUVIMED